A new overview makes Medicinrådet’s type 2 diabetes recommendations easier to use in practice.
What is new
-
A new overview and algorithm give primary care a quick view of recommended pharmacological treatment for type 2 diabetes.
-
The material brings together Medicinrådet’s treatment recommendations from the May 2026 guidance.
-
It includes information on efficacy, prices, side effects and other relevant details.
-
Prices will be updated if they change significantly, for example due to patent expiry or supply issues.
-
The overview replaces the previous medicine recommendation in this area and will also be part of the national basis list expected in autumn 2026.
Aim
The stated aim is to give doctors and other health professionals a practical tool that can be used directly in a busy clinical setting.
Read more at https://medicinraadet.dk/nyheder/2026/nyt-overblik-over-laegemidler-til-type-2-diabetes
